Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West
Yi‐Hao Yen(Chang Gung University), Tsung‐Hui Hu(National Sun Yat-sen University), Jen-Yu Cheng(Chang Gung University), Yueh‐Wei Liu(Kaohsiung Chang Gung Memorial Hospital), Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Yu‐Fan Cheng(Shanghai Medical College of Fudan University), Chee‐Chien Yong(Kaohsiung Chang Gung Memorial Hospital), Yen‐Yang Chen(Chang Gung University), Jing‐Houng Wang(Kaohsiung Chang Gung Memorial Hospital), Chih‐Che Lin(Kaohsiung Chang Gung Memorial Hospital)
Cited by 12
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
|Gastroenterology|2007|232
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|221
Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan
|World Journal of Gastroenterology|2006|217